ClinicalTrials.Veeva

Menu

Metoclopramide on Gastric Emptying in Mechanically Ventilated Patients

T

Tanta University

Status and phase

Completed
Phase 4

Conditions

Gastric Emptying
Randomized Controlled Trial
Metoclopramide
Mechanically Ventilation

Treatments

Drug: Metoclopramide
Drug: Placebo

Study type

Interventional

Funder types

Other

Identifiers

NCT05641051
35298/2/22

Details and patient eligibility

About

The aim of this study is to evaluate the prokinetic effect of metoclopramide on gastric emptying in critically ill mechanically ventilated patients .

Full description

More than 50% of patients in ICU have gastric dysmotility, which leads to slow gastric emptying(GE) and high gastric residual volume (GRV) and is associated with increased mortality in these patients

Enrollment

80 patients

Sex

All

Ages

20 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Patients' age 20 - 60 years.
  2. Either gender.
  3. Mechanically ventilated head trauma patients.
  4. Patients receiving enteral feeding via nasogastric tube.

Exclusion criteria

  1. Patients with contraindications to enteral feeding.
  2. Patients with extrapyramidal manifestations.
  3. Patients with known allergy to metoclopramide.
  4. Patients with seizures.
  5. Patients with renal or hepatic diseases.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

80 participants in 2 patient groups, including a placebo group

Metoclopramide group
Experimental group
Description:
Patients will receive 10 mg intravenous metoclopramide / 6 hours.
Treatment:
Drug: Metoclopramide
Control group
Placebo Comparator group
Description:
Patients will receive the same volume of intravenous placebo / 6 hours.
Treatment:
Drug: Placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems